Coversyl: Effective Blood Pressure and Heart Failure Management
Coversyl
| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.60 | $48.00 (0%) | 🛒 Add to cart |
| 60 | $1.40 | $96.00 $84.00 (12%) | 🛒 Add to cart |
| 90 | $1.20 | $144.00 $108.00 (25%) | 🛒 Add to cart |
| 120 | $1.15 | $192.00 $138.00 (28%) | 🛒 Add to cart |
| 180 | $1.10 | $288.00 $198.00 (31%) | 🛒 Add to cart |
| 270 | $0.90 | $432.00 $243.00 (44%) | 🛒 Add to cart |
| 360 | $0.80
Best per pill | $576.00 $288.00 (50%) | 🛒 Add to cart |
| Product dosage: 4mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.00 | $40.00 (0%) | 🛒 Add to cart |
| 30 | $1.70 | $60.00 $51.00 (15%) | 🛒 Add to cart |
| 60 | $1.50 | $120.00 $90.00 (25%) | 🛒 Add to cart |
| 90 | $1.33 | $180.00 $120.00 (33%) | 🛒 Add to cart |
| 120 | $1.20 | $240.00 $144.00 (40%) | 🛒 Add to cart |
| 180 | $1.15 | $360.00 $207.00 (42%) | 🛒 Add to cart |
| 270 | $1.10 | $540.00 $297.00 (45%) | 🛒 Add to cart |
| 360 | $1.00
Best per pill | $720.00 $360.00 (50%) | 🛒 Add to cart |
| Product dosage: 8mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $3.00 | $60.00 (0%) | 🛒 Add to cart |
| 30 | $2.80 | $90.00 $84.00 (7%) | 🛒 Add to cart |
| 60 | $2.60 | $180.00 $156.00 (13%) | 🛒 Add to cart |
| 90 | $2.40 | $270.00 $216.00 (20%) | 🛒 Add to cart |
| 120 | $2.20 | $360.00 $264.00 (27%) | 🛒 Add to cart |
| 180 | $2.00 | $540.00 $360.00 (33%) | 🛒 Add to cart |
| 270 | $1.70 | $810.00 $459.00 (43%) | 🛒 Add to cart |
| 360 | $1.50
Best per pill | $1080.00 $540.00 (50%) | 🛒 Add to cart |
Coversyl (perindopril erbumine) is an angiotensin-converting enzyme (ACE) inhibitor prescribed for the management of essential hypertension and stable coronary artery disease, often as part of a comprehensive cardiovascular treatment strategy. It functions by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing peripheral arterial resistance. This mechanism not only effectively lowers blood pressure but also decreases the cardiac workload, offering a dual therapeutic benefit for patients with hypertension and certain heart conditions. Its evidence-based profile is supported by extensive clinical trials, establishing it as a cornerstone therapy in modern cardiology practice.
Features
- Active ingredient: Perindopril erbumine
- Drug class: Angiotensin-converting enzyme (ACE) inhibitor
- Available in 2 mg, 4 mg, and 8 mg tablet strengths
- Once-daily oral administration
- Proven efficacy in reducing systolic and diastolic blood pressure
- Demonstrated benefit in improving endothelial function
- Suitable for long-term maintenance therapy
Benefits
- Significantly reduces both systolic and diastolic blood pressure, lowering the risk of stroke, myocardial infarction, and other cardiovascular events.
- Provides cardioprotective effects by reducing cardiac afterload and improving coronary blood flow.
- Slows the progression of renal disease in hypertensive patients with diabetes by reducing proteinuria.
- Enhances exercise tolerance and functional capacity in patients with chronic heart failure.
- Offers convenient once-daily dosing that supports medication adherence.
- Demonstrates a favorable safety and tolerability profile in most patient populations when used as directed.
Common use
Coversyl is primarily indicated for the treatment of essential hypertension, either as monotherapy or in combination with other antihypertensive agents. It is also approved for use in patients with stable coronary artery disease to reduce the risk of cardiovascular events. Additionally, it may be prescribed as part of a management plan for chronic heart failure, usually in conjunction with diuretics and/or beta-blockers. Off-label uses may include the management of diabetic nephropathy and certain forms of secondary hypertension, though these should only be pursued under specialist supervision.
Dosage and direction
The recommended initial dose for hypertension is 4 mg once daily, which may be increased to 8 mg after one month if necessary. For elderly patients or those with renal impairment, a starting dose of 2 mg daily is advised. Tablets should be taken orally, preferably at the same time each day, with or without food. It is important to swallow the tablet whole with a glass of water; it should not be crushed or chewed. Dosage adjustments should be made based on therapeutic response and tolerability, under medical supervision.
Precautions
Before initiating therapy, assess renal function and electrolyte levels. Use with caution in patients with renal artery stenosis, as ACE inhibitors can cause reversible increases in blood urea and serum creatinine. Monitor blood pressure closely during the initial dose titration period. Avoid use during pregnancy, particularly in the second and third trimesters, due to the risk of fetal injury. Caution is advised in patients with a history of angioedema, collagen vascular disease, or those undergoing major surgery. Concomitant use with potassium-sparing diuretics or potassium supplements requires careful monitoring to prevent hyperkalemia.
Contraindications
Coversyl is contraindicated in patients with a history of hypersensitivity to perindopril or any other ACE inhibitor. It must not be used in patients with hereditary or idiopathic angioedema. Contraindications also include bilateral renal artery stenosis, previous angioedema related to previous ACE inhibitor therapy, and during the second and third trimesters of pregnancy. It is not recommended for use in combination with aliskiren in patients with diabetes or renal impairment.
Possible side effects
Common adverse reactions may include persistent dry cough, dizziness, headache, fatigue, and gastrointestinal disturbances such as nausea or diarrhea. Less frequently, orthostatic hypotension, rash, and taste disturbances may occur. Serious side effects, though rare, can include angioedema (swelling of the face, lips, tongue, or throat), hyperkalemia, neutropenia/agranulocytosis, and renal impairment. Patients should seek immediate medical attention if they experience symptoms of angioedema, significant dizziness, fainting, or signs of infection such as fever or sore throat.
Drug interaction
Coversyl may interact with several medication classes. Concomitant use with diuretics may potentiate hypotension. Nonsteroidal anti-inflammatory drugs (NSAIDs) can reduce the antihypertensive effect and increase the risk of renal impairment. Concurrent administration with lithium may increase lithium levels and toxicity. Potassium-sparing diuretics, potassium supplements, or salt substitutes containing potassium can lead to hyperkalemia. Use with caution alongside other antihypertensive agents, as additive effects may occur. Always inform the prescribing physician of all medications, including over-the-counter drugs and supplements.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended, as it may increase the risk of adverse effects.
Overdose
Symptoms of overdose may include severe hypotension, bradycardia, circulatory shock, electrolyte disturbances, and renal failure. Management involves supportive measures, including volume expansion with intravenous normal saline to maintain blood pressure. Hemodialysis may be effective in removing perindopril from the systemic circulation. Close monitoring of vital signs, electrolyte balance, and renal function is essential in cases of suspected overdose.
Storage
Store at room temperature (15–30°C or 59–86°F) in a dry place, protected from light and moisture. Keep the container tightly closed and out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Dispose of any unused medication properly according to local guidelines, avoiding flushing or pouring into drains.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or discontinuing any medication. Individual patient responses may vary, and therapeutic decisions should be based on a comprehensive clinical assessment.
Reviews
Clinical studies and meta-analyses consistently demonstrate the efficacy of perindopril in reducing blood pressure and cardiovascular risk. The EUROPA trial showed a significant reduction in cardiovascular events in patients with stable coronary artery disease. Many clinicians report good patient tolerance and adherence due to its once-daily dosing. Some patients note the dry cough as a bothersome side effect, though it often resolves upon discontinuation. Overall, it remains a well-regarded option within its therapeutic class.